Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Sutter Health unveils $1bn expansion to transform East Bay healthcare In a move that reflects its commitment to healthcare access expansion, Sutter Health has unveiled an ambitious plan… byPallavi MadhirajuFebruary 19, 2025